A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 18,792 shares of TEVA stock, worth $415,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,792
Previous 2,055,515 99.09%
Holding current value
$415,115
Previous $33.4 Million 98.99%
% of portfolio
0.0%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.81 - $18.96 $32.2 Million - $38.6 Million
-2,036,723 Reduced 99.09%
18,792 $338,000
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $4.83 Million - $6.57 Million
-377,752 Reduced 15.52%
2,055,515 $33.4 Million
Q1 2024

May 14, 2024

SELL
$10.67 - $14.43 $9.04 Million - $12.2 Million
-846,794 Reduced 25.82%
2,433,267 $34.3 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $1.5 Million - $1.96 Million
-184,146 Reduced 5.32%
3,280,061 $34.2 Million
Q3 2023

Nov 13, 2023

SELL
$7.48 - $10.7 $640,108 - $915,663
-85,576 Reduced 2.41%
3,464,207 $35.3 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $2.17 Million - $2.86 Million
301,583 Added 9.28%
3,549,783 $26.7 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $4.2 Million - $5.71 Million
-502,100 Reduced 13.39%
3,248,200 $28.7 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $3.48 Million - $4.15 Million
437,400 Added 13.2%
3,750,300 $34.2 Million
Q3 2022

Nov 10, 2022

SELL
$6.86 - $11.95 $1.04 Million - $1.81 Million
-151,800 Reduced 4.38%
3,312,900 $26.7 Million
Q2 2022

Aug 12, 2022

SELL
$7.38 - $10.4 $84,132 - $118,560
-11,400 Reduced 0.33%
3,464,700 $26.1 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $5.13 Million - $6.58 Million
700,500 Added 25.24%
3,476,100 $32.6 Million
Q4 2021

Feb 11, 2022

SELL
$7.9 - $10.19 $237,790 - $306,719
-30,100 Reduced 1.07%
2,775,600 $22.2 Million
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $2.12 Million - $2.57 Million
252,800 Added 9.9%
2,805,700 $27.3 Million
Q2 2021

Aug 12, 2021

BUY
$9.9 - $11.56 $5.53 Million - $6.46 Million
559,000 Added 28.04%
2,552,900 $25.3 Million
Q1 2021

May 13, 2021

BUY
$10.34 - $12.81 $1.84 Million - $2.28 Million
178,300 Added 9.82%
1,993,900 $23 Million
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $15.6 Million - $20 Million
1,815,600 New
1,815,600 $17.5 Million
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $233,700 - $300,150
-15,000 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $218,850 - $357,600
15,000 New
15,000 $231,000
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $777,114 - $946,485
-36,900 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $618,813 - $911,799
36,900 New
36,900 $897,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.